CPSE:RBREW
CPSE:RBREWBeverage

Royal Unibrew (CPSE:RBREW) Share Buy-Back Sparks Fresh Look at Company Valuation

Royal Unibrew (CPSE:RBREW) has kicked off a share buy-back program, beginning August 27 and running until December 19, 2025. This move typically indicates management’s confidence in the company and can influence investor attitudes. See our latest analysis for Royal Unibrew. Despite Royal Unibrew’s new buy-back program hinting at management’s confidence, the stock has lost some momentum lately. Over the past year, the total shareholder return was -7.9%, while the three-year gain was 7.7%,...
CPSE:CARL B
CPSE:CARL BBeverage

A Fresh Look at Carlsberg (CPSE:CARL B) Valuation After UK Soft Drinks Expansion and Poppi Deal

Carlsberg (CPSE:CARL B) has taken several steps to boost its presence in the UK soft drinks market, announcing a major investment in a new canning line at its Rugby facility. In addition to the expansion, the exclusive distribution of Poppi prebiotic soda adds a growth angle worth watching. See our latest analysis for Carlsberg. These strategic moves come as Carlsberg’s share price recently softened, with a 90-day return of -17.4%, even as the year-to-date share price return remains positive...
CPSE:ORSTED
CPSE:ORSTEDRenewable Energy

Ørsted (CPSE:ORSTED): Are Shares Undervalued After Recent Volatility?

Ørsted (CPSE:ORSTED) shares have caught the attention of investors, as the stock price has seen significant swings over the past month. Recent activity has brought renewed discussion about the company’s outlook and how market sentiment is shifting. See our latest analysis for Ørsted. Zooming out, Ørsted's share price has remained under pressure this year, reflecting a cautious market mood as investors weigh renewable energy outlooks and recent sector challenges. While the 1-year total...
CPSE:VWS
CPSE:VWSElectrical

3 European Stocks Estimated To Be Undervalued By Up To 36.7%

As European markets navigate a period of mixed performance, with the pan-European STOXX Europe 600 Index slightly lower and major stock indexes showing varied results, investors are keenly assessing monetary policy decisions and economic indicators. In this environment, identifying undervalued stocks becomes crucial as they can offer potential opportunities for growth despite broader market fluctuations.
CPSE:HLUN B
CPSE:HLUN BPharmaceuticals

Is Lundbeck Still Attractive After 12.6% Monthly Surge and Positive Neurology Pipeline Updates?

If you are eyeing H. Lundbeck stock and trying to decide whether now is the right time to move, you are not alone. Investors have noticed the recent uptick, with shares climbing 5.6% in the past week and 12.6% over the last month. Year to date, the return is a solid 6.9%. What really stands out is the 91.1% gain over the past three years. Clearly, the market has warmed up to Lundbeck, giving some the sense that the momentum could continue, or perhaps that all the easy gains are already...